Ra Medical Systems

Ra Medical Systems is a healthcare startup based in the United States. Founded in 2002, the company's mission is to "Save lives, limbs and improve patients’ quality of life." Ra Medical Systems initially focused on designing, developing, and commercializing excimer lasers for the treatment of vascular and dermatological diseases. In October 2004, the company launched the Pharos excimer laser system for the treatment of dermatological conditions such as psoriasis and vitiligo. However, in August 2021, Ra Medical Systems shifted its focus to the larger vascular business opportunity and sold its dermatological products and services. The company's key product is the DABRA laser and single-use catheter, which received FDA 510(k) clearance in May 2017 for crossing chronic total occlusions in patients with lower extremity vascular disease. This minimally-invasive excimer laser and catheter system is used in the endovascular treatment of vascular blockages resulting from peripheral artery disease (PAD). Ra Medical Systems manufactures the DABRA excimer laser and catheters in a 32,000-square-foot facility in Carlsbad, California, which is ISO 13485 certified and licensed by the state of California. The company recently secured a $7.60M Post-IPO Equity investment on 17 October 2022. Overall, Ra Medical Systems is positioned to make a significant impact in the healthcare industry with its innovative vascular treatment technology and a strategic shift towards capitalizing on the vascular business opportunity.